Published in Clin Cancer Res on March 01, 2008
The 21-gene recurrence score and locoregional recurrence in breast cancer patients. Ann Surg Oncol (2014) 1.40
Local control by radiotherapy: is that all there is? Breast Cancer Res (2008) 1.18
Surgery-induced wound response promotes stem-like and tumor-initiating features of breast cancer cells, via STAT3 signaling. Oncotarget (2014) 0.99
Intraoperative radiotherapy in the treatment of breast cancer: a review of the evidence. Int J Breast Cancer (2011) 0.92
Boost IORT in Breast Cancer: Body of Evidence. Int J Breast Cancer (2014) 0.89
Portrait of inflammatory response to ionizing radiation treatment. J Inflamm (Lond) (2015) 0.89
Partial breast irradiation: a review of techniques and indications. Br J Radiol (2010) 0.88
Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic. J Pathol (2013) 0.86
Intraoperative radiotherapy for breast cancer. Gland Surg (2014) 0.84
Postlumpectomy focal brachytherapy for simultaneous treatment of surgical cavity and draining lymph nodes. Int J Radiat Oncol Biol Phys (2010) 0.83
Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway. Oncogene (2016) 0.83
High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery. Oncotarget (2015) 0.83
Intraoperative radiotherapy (IORT) with low-energy photons as a boost in patients with early-stage oral cancer with the indications for postoperative radiotherapy : treatment feasibility and preliminary results. Strahlenther Onkol (2010) 0.82
Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers. Genome Med (2014) 0.81
INTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation study. BMC Cancer (2014) 0.80
Biology of high single doses of IORT: RBE, 5 R's, and other biological aspects. Radiat Oncol (2017) 0.79
Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF. Proc Natl Acad Sci U S A (2016) 0.78
Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs. Cell Mol Life Sci (2016) 0.77
Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides. Phys Med Biol (2011) 0.76
Effect of surgical wound fluids after intraoperative electron radiotherapy on the cancer stem cell phenotype in a panel of human breast cancer cell lines. Oncol Lett (2016) 0.75
Intraoperative full-dose of partial breast irradiation with electrons delivered by standard linear accelerators for early breast cancer. Int J Breast Cancer (2014) 0.75
Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer. Aging (Albany NY) (2016) 0.75
Is there a role for intraoperative radiation therapy in patients with resected pancreatic adenocarcinoma? Ann Surg Oncol (2009) 0.75
Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions. Springerplus (2015) 0.75
Intraoperative radiotherapy (IORT) as boost in breast cancer. Radiat Oncol (2017) 0.75
Time-tuning cancer therapy. Aging (Albany NY) (2015) 0.75
Modelling the radiobiological effect of intraoperative X-ray brachytherapy for breast cancer using an air-filled spherical applicator. J Contemp Brachytherapy (2016) 0.75
Intraoperative Period and Breast Cancer: Review. J Breast Health (2013) (2014) 0.75
Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy. Strahlenther Onkol (2016) 0.75
Wound fluids affect miR-21, miR-155 and miR-221 expression in breast cancer cell lines, and this effect is partially abrogated by intraoperative radiation therapy treatment. Oncol Lett (2017) 0.75
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell (2008) 7.56
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol (2013) 6.79
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A (2012) 5.07
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial. Lancet Oncol (2011) 4.67
Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med (2005) 3.35
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Natl Cancer Inst (2008) 3.16
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. J Clin Oncol (2008) 3.14
Intraoperative radiotherapy for breast cancer. Lancet Oncol (2004) 2.91
The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer (2006) 2.67
p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell (2005) 2.65
Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget (2010) 2.64
[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur J Nucl Med Mol Imaging (2006) 2.63
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum (2013) 2.52
miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res (2012) 2.52
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med (2011) 2.46
Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A (2010) 2.05
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A (2010) 1.99
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene (2002) 1.99
TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol (2005) 1.83
Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets (2011) 1.66
Vinculin acts as a sensor in lipid regulation of adhesion-site turnover. J Cell Sci (2005) 1.66
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell (2008) 1.62
Breast cancer in the elderly. J Clin Oncol (2007) 1.60
Clinical presentation and outcome of colorectal cancer in HIV-positive patients: a clinical case-control study. Onkologie (2009) 1.58
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol (2004) 1.56
Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer (2004) 1.55
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene (2005) 1.53
A mathematical model of breast cancer development, local treatment and recurrence. J Theor Biol (2006) 1.51
Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy. Int J Radiat Oncol Biol Phys (2010) 1.46
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A (2013) 1.44
The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition. Mol Cell Biol (2009) 1.43
Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer. PLoS One (2013) 1.43
EMILIN-1 deficiency induces elastogenesis and vascular cell defects. Mol Cell Biol (2004) 1.41
MCP-1 induces migration of adult neural stem cells. Eur J Cell Biol (2004) 1.39
Feasibility and diagnostic agreement in teledermatopathology using a virtual slide system. Hum Pathol (2007) 1.39
Dynamic response to heat--a novel physical characteristic of breast cancer. Int J Surg (2008) 1.38
Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res (2006) 1.34
The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells. Cancer Res (2002) 1.31
Extracellular matrix: a matter of life and death. Connect Tissue Res (2008) 1.28
microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget (2014) 1.28
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood (2010) 1.27
Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys (2010) 1.24
Targeting triple negative breast cancer: is p53 the answer? Cancer Treat Rev (2013) 1.23
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A (2014) 1.22
Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J Biol Chem (2002) 1.22
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res (2009) 1.22
Targeted therapies: Using β-blockers to inhibit breast cancer progression. Nat Rev Clin Oncol (2011) 1.21
Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer (2003) 1.21
Food groups and risk of non-Hodgkin lymphoma: a multicenter, case-control study in Italy. Int J Cancer (2006) 1.21
Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas. Carcinogenesis (2005) 1.18
Analysis methods of human cell migration. Exp Cell Res (2005) 1.18
A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients. Cancer Immunol Immunother (2005) 1.17
p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. Mol Cancer Ther (2008) 1.16
Extravasation of leukocytes in comparison to tumor cells. Cell Commun Signal (2008) 1.16
3D-extravasation model -- selection of highly motile and metastatic cancer cells. Semin Cancer Biol (2005) 1.14
Emilin1 deficiency causes structural and functional defects of lymphatic vasculature. Mol Cell Biol (2008) 1.14
The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin. Am J Pathol (2010) 1.13
Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development. Cancer Cell (2007) 1.13
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes. Cancer Immunol Immunother (2004) 1.12
Ischemic heart disease after breast cancer radiotherapy. N Engl J Med (2013) 1.11
beta 1 Integrin-dependent cell adhesion to EMILIN-1 is mediated by the gC1q domain. J Biol Chem (2002) 1.11
Regulation of BRCA1 transcription by specific single-stranded DNA binding factors. Mol Cell Biol (2003) 1.10
Breast metastasis of primary colon cancer with micrometastasis in the axillary sentinel node: a metastasis that metastasized? Diagn Pathol (2011) 1.09
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Lab Invest (2010) 1.09
Mutated beta-catenin evades a microRNA-dependent regulatory loop. Proc Natl Acad Sci U S A (2011) 1.08
p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. Mol Cell Biol (2010) 1.08
Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol (2011) 1.08
Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol (2002) 1.08
Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. Am J Pathol (2009) 1.08
Clinical and dermoscopic features of porokeratosis of Mibelli. Arch Dermatol (2009) 1.08
Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo. Cell Cycle (2014) 1.07